NSAID, statin use may reduce risks for Barrett's patients

03/8/2010 | Medscape (free registration)

A study found Barrett's esophagus patients taking proton-pump inhibitors and either a nonsteroidal anti-inflammatory drug or a statin reduced their risk of esophageal adenocarcinoma. Data showed those who filled prescriptions for NSAID/aspirin were 36% less likely to have esophageal cancer and those who filled statin prescriptions had a 45% reduced risk.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX